Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Gains from Sales and Divestitures (2017 - 2020)

Axogen (AXGN) has 4 years of Gains from Sales and Divestitures data on record, last reported at $168311.0 in Q3 2020.

  • For Q3 2020, Gains from Sales and Divestitures changed N/A year-over-year to $168311.0; the TTM value through Sep 2020 reached $168311.0, changed N/A, while the annual FY2019 figure was $86405.0, 1108.46% up from the prior year.
  • Gains from Sales and Divestitures reached $168311.0 in Q3 2020 per AXGN's latest filing, up from $86405.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $168311.0 in Q3 2020 and bottomed at $7150.0 in Q4 2017.
  • Average Gains from Sales and Divestitures over 4 years is $67254.0, with a median of $46777.5 recorded in 2017.
  • Peak YoY movement for Gains from Sales and Divestitures: changed 0.0% in 2018, then surged 1108.46% in 2019.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $7150.0 in 2017, then changed by 0.0% to $7150.0 in 2018, then soared by 1108.46% to $86405.0 in 2019, then soared by 94.79% to $168311.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Gains from Sales and Divestitures were $168311.0 in Q3 2020, $86405.0 in Q4 2019, and $7150.0 in Q4 2018.